Home / Pharma News

Pharma News

India approves Mylan’s purchase of Agila

Generics giant Mylan announced on 3 September 2013 that its proposed acquisition of generics injectables maker Agila Specialties (Agila) from Strides Arcolab for Rs 5,168-crore (US$1.6 billion) had been cleared by the Indian Government.

Johnson & Johnson warns of shortages of cancer drug Doxil

Janssen Pharmaceutical Companies (Janssen), a division of healthcare giant Johnson & Johnson, has warned of impending shortages of its ovarian cancer drug Doxil (doxorubicin).

Sandoz launches new device for its biosimilar somatropin

Sandoz, the generic drug division of Swiss drug giant Novartis, announced on 23 September 2013 the launch of a new delivery device for its biosimilar somatropin product (Omnitrope) in the UK.

Akorn to buy Hi-Tech Pharmacal for US$640 million

Generic eye-drugmaker Akorn has entered into a deal to buy Hi-Tech Pharmacal (Hi-Tech) for US$640 million in cash to expand into oral liquids and ointments, including cold and cough treatments.

Endo to buy specialty generic drugmaker Boca Pharmacal

Specialty pharmaceutical maker Endo Health Solutions (Endo) announced on 28 August 2013 that its generics subsidiary, Qualitest, has agreed to buy specialty generic drugmaker Boca Pharmacal (Boca) for US$225 million in cash.

Actavis and Bioton form joint venture for insulin

Icelandic generics manufacturer Actavis announced on 30 January 2012 that it had formed a joint venture company with Polish biotechnology company Bioton for the development and registration of insulin products, including analogue insulins.

Philippines urged to import drugs from Bangladesh

The Prime Minister of Bangladesh, Ms Sheikh Hasina, on 5 May 2013 urged the Philippines to import pharmaceutical products from Bangladesh, particularly for the countries governmental hospitals and clinics, due to the significant cost-savings to be made.

Generics manufacturers increase investment in injectables

Generic drugmaker Zydus Cadila, the fifth largest pharmaceutical company in India, is set to invest about US$15.8 million in building an FDA-approved injectables-manufacturing plant. The news in August 2013 came just as Aurobindo Pharma announced plans to spin-off its injectables business to strengthen that side of its operations further.

Fresenius Kabi sets up generics joint venture in Indonesia

Fresenius Kabi, the generics unit of healthcare giant Fresenius, announced on 19 August 2013 that it had set up a joint venture with Indonesia-based PT Soho Global Health, acquiring a 51% share in its subsidiary PT Ethica Industri Farmasi.

Perrigo expands global ambitions with Elan buy

US-based generics maker Perrigo Company (Perrigo) announced on 29 July 2013 that it would acquire Irish biotechnology company Elan Corporation (Elan) for US$8.6 billion.

Generics News Research General


Biosimilars News Research General